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ABSTRACT
BACKGROUND: Sulfasalazine, an inhibitor of cyclooxygenase, 5-lipoxygenase,
and nuclear factor KB (NF-KB), has been found to alleviate oxidative damage, pro-
inflammatory cytokine production, bile-duct proliferation, neutrophil infiltration,
and fibrosis. Therefore, it may have a potential effect in attenuating lipid peroxidation
and histologic liver damage in patients with biliary obstruction and biliary obstruction
with sepsis.
OBJECTIVE: The aim of this study was to investigate the effect of sulfasalazine
on lipid peroxidation and histologic liver damage due to obstructive jaundice (0]) and
to 0] with lipopolysaccharide (LPS)-induced sepsis in an experimental model.
METHODS: Male Wistar rats, weighing 150 to 220 g, were randomized into
6 groups: 0]; 0] + LPS; 0] + sulfasalazine; 0] + sulfasalazine + LPS (sulfasalazine
administered before sepsis); 0] + LPS + sulfasalazine (sulfasalazine administered after
sepsis); and sham. Liver malondialdehyde (MDA) and myeloperoxidase (MPO) activities
were assessed to monitor lipid peroxidation and neutrophil infiltration in liver tissue.
Histologic liver damage was evaluated with hematoxylin-eosin stained slides. Liver
tissue NF-KB and caspase-3 expression were studied immunohistopathologically to
evaluate lipid peroxidation, liver damage, and hepatocyte apoptosis.
RESULTS: Forty-eight rats were evenly randomized into 6 groups of 8. MDA
(P = 0.00l), MPO (P = 0.00l), NF-KB (P = 0.003), caspase-3 expression (P = 0.002),
and liver injury scores (P = 0.002) increased significantly in the 0] group com-
pared with the sham group. Compared with the 0] group, MDA (P = 0.030) and
MPO levels (P = 0.00l), and liver injury scores (P = 0.033) were decreased signifi-
cantly in the 0] + sulfasalazine group. In the 0] + sulfasalazine + LPS and 0] + LPS +
sulfasalazine groups, MDA (P = 0.008 and P = 0.023, respectively) and MPO (both,
P = 0.001) were significantly decreased; however, liver NF-KB, caspase-3 expression,
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and liver injury scores were not significantly different compared with the 0] + LPS
group. There was no significant difference between the 0] + LPS + sulfasalazine and
0] + sulfasalazine + LPS groups in regard to all end points when comparing the effects
of sulfasalazine administered before or after sepsis.
CONCLUSIONS: Sulfasalazine was associated with decreased neutrophil accumu-
lation and lipid peroxidation in these rats with 0]. Administration of sulfasalazine
before or after LPS-induced sepsis was associated with a reduction in lipid peroxidation
and neutrophil accumulation; however, it did not attenuate histologic liver damage.
There was no difference between the findings when sulfasalazine was administered
before or after sepsis in 0]. (Curr Ther Res Clin Exp. 2009;70:299-315) © 2009
Excerpta Medica Inc.
KEY WORDS: sulfasalazine, lipid peroxidation, nuclear factor KB, caspase-3,
liver injury.
INTRODUCTION
Obstructive jaundice (0]) is a condition caused by occlusion of the common bile duct
or its tributaries.1,2 0] leads to complications such as biliary infection, septic shock,
hepatic parenchymal injury, and multiple organ dysfunctions that carry a high risk for
mortality. 0] is associated with many clinical conditions such as gallstones, benign
stricture or tumor of bile duct, and complication of biliary surgery or pancreatitis, and
may lead to serious complications such as wound breakdown, sepsis, coagulopathy,
gastrointestinal hemorrhage, cardiovascular problems, immune depression, and hepatic
and renal failure. 1
The mechanisms and mediators responsible for the pathogenesis of liver damage from
acute biliary obstruction remain largely unknown. Intrahepatic accumulation of toxic bile
salts is thought to be one of the primary causes.3,4 Increased production of proinflamma-
tory cytokines, such as tumor necrosis factor-a (TNF-a) and interleukin (IL)-113 and IL-6,
has been implicated.s Data also suggest that oxidative stress is an important factor. 6 Lipid
peroxidation is an important problem in 0], in which free radical production is increased
and antioxidative activity is reduced.7 Nitric oxide formation and increased expression of
inducible nitric oxide synthase (iNOS) take place.s Nitric oxide reacts with free oxygen
radicals, and this leads to the formation of the harmful peroxynitrite anion (ONOO-),
which can lead to lipid peroxidation, cellular damage, and apoptosis.
Another important problem associated with 0] is the increased incidence of
endotoxemia. 1,9-12 The absence of bile in the gastrointestinal tract stimulates bacterial
overgrowth and bacterial translocation. Increased concentrations of bacteria and endo-
toxin in the portal blood lead to systemic endotoxemia. 13 ,14 Systemic endotoxemia
developed in 0] is the result of the depression in the clearance of lipopolysaccharide
(LPS) and other endotoxins in the portal circulation by Kupffer cells in the liver.
In 0], hepatic Kupffer cells' endocytosis is impaired and their endotoxin clearance
ability is decreased. Portal endotoxemia, which is the result of an impaired intestinal
barrier, and systemic endotoxemia, which is developed as a result of impaired function
of Kupffer cells, lead to sepsis. 1,12,lS,16
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In sepsis, neutrophilic inflammation appears to be the result of the local production
of cytokines, chemokines, endothelial-leukocyte adhesion molecules, and enzymes,
such as iNOS and cyclooxygenase-2 (COX-2). The expression of iNOS can be induced
by injection ofLPS. 17 The production of iNOS and COX-2 are regulated by the ubiq-
uitous transcription factor, complex nuclear factor KB (NF-KB). NF-KB is a DNA-
binding protein necessary for directing high-level transcription of many proinflam-
matory genes. 1S ONOO-, free oxygen radicals, and environment factors lead to DNA
strand breakage, which triggers the activation of poly (adenosine diphosphate-ribose)
synthase (PARS) .19,20 PARS is an energy-requiring enzyme that plays a role in the repair
of strand breaks in DNA. Its activation results in a substantial depletion of nicotina-
mide adenine dinucleotide, thus leading to cell dysfunction. 21
Hepatocyte injury during cholestasis depends in part on the release of proinflam-
matory mediators that cause neutrophils to accumulate in the liver and become acti-
vated, damaging hepatocytes. 22 On the other hand, cellular and molecular events
during the course of liver injury in 0] have centered on the role of resident hepatic
macrophages, or Kupffer cells. Activation of macrophages leads to invasion polymor-
phonuclear leukocytes, secretion and upregulation of proinflammatory mediators, such
as TNF-a, IL-l, and IL-6, and recruitment of systemic macrophages to the site of in-
jury.22,23 In addition to sinusoids, neutrophils adhere in portal and postsinusoidal
venules and extravasate from these locations. 24,25
Sulfasalazine consists of 5-aminosalicylic acid (5-ASA) and sulfapyridine, linked
by an azo band. Sulfapyridine and 5-ASA inhibit cyclooxygenase and 5-lipoxygenase.
Research has suggested that sulfasalazine is a potent and specific inhibitor of NF-KB.26
In addition, sulfasalazine has antioxidant properties; it is a strong scavenger of free
radicals. 27 Treatment with sulfasalazine may alleviate liver oxidative damage, pro-
inflammatory cytokine production, ductular proliferation, neutrophil infiltration, and
fibrosis in bile-duct ligated rats. 2S
The beneficial effects of sulfasalazine suggest that it might be useful in attenuating
liver damage in patients with biliary obstruction and sepsis. The aim of this study was to
investigate the effect of sulfasalazine on lipid peroxidation and histologic liver damage due
to 0] and to 0] with LPS-induced sepsis in a rat model.
MATERIALS AND METHODS
The experiments described in this article were performed in adherence to the Turkish
National Institutes of Health guidelines on the use of experimental animals. 29 Ap-
proval was obtained from the ethics committee of the Mersin University Medical
School, Mersin, Turkey. Male Wistar rats, weighing 150 to 220 g, were housed at
constant temperature with a light/dark exposure period of 14/10 hours. Animals
were allowed access to standard rat chow and water ad libitum with an acclima-
tion period of::o-5 days prior to use in these experiments. The experiments were
performed in The Animal Experimental Laboratory of the Mersin University
Medical School.
We randomized the rats into 6 groups of equal size. The randomization was
performed with Minitab version 13 (Minitab Inc., State College, Pennsylvania).
301
CURRENT THERAPEUTIC RESEARCH
In the 0] group, 0] was constituted by common bile-duct ligation (BDL) for 5 days.
In the 0] + LPS group, after constituting 0] with BDL, LPS 10 mg/kg (Escherichia coli
LPS serotype 0127:B8, 100 mg, Sigma Chemical Co., St. Louis, Missouri) was injected
intraperitoneally on the sixth day. LPS was used to establish sepsis. In the 0] + sulfasala-
zine group, starting on the sixth day of BDL, sulfasalazine 100 mg/kg (S0883-lOG,
Sigma Chemical Co.) was injected intraperitoneally for 5 days. In the 0] + sulfasalazine +
LPS group, starting on the sixth day of BDL, sulfasalazine 100 mg/kg was injected in-
traperitoneally for 5 days and LPS 10 mg/kg was injected intraperitoneally 6 hours be-
fore the rats were euthanized on the tenth day. In the 0] + LPS + sulfasalazine group,
LPS 10 mg/kg was injected intraperitoneally on the sixth day of BDL and sulfasala-
zine 100 mg/kg was injected intraperitoneally for 5 days. Sham operation was performed
in the sham group.
SURGICAL PROCEDURES
Rats were anesthetized with 1M ketamine 50 mg/kg and xylazine 7 mg/kg. The chest
and abdomen were shaved and each animal was fixed in a supine position on the operating
table. The abdomen was cleaned with 1% polyvinyl iodine and, when dry, the operating
field was covered with a sterile drape and median laparotomy was performed.
The sham operation consisted of only mobilization of the common bile duct, without
ligation.
The experimental jaundice was created by ligation of the common bile duct accord-
ing to the technique described by Lee. 30 The common bile duct was exposed and li-
gated twice by silk suture, and the portion between the ligatures was resected. The
abdominal wall was closed with interrupted silk sutures and the edges of the skin were
approximated with a subcuticular stitch. 0] was constituted by BDL for 5 days.
After completion of each arm of the study, rats in all arms were euthanized at the
end of the tenth day. Before being euthanized, rats were anesthetized with 1M keta-
mine 50 mg/kg, and hepatectomies were performed through repeat laparotomy. Liver
malondialdehyde (MDA) and myeloperoxidase (MPO) activities were determined to
assess lipid peroxidation and neutrophil infiltration in liver tissue. Histologic liver
damage was evaluated by light microscopic examination of hematoxylin-eosin stained
slides. Liver tissue NF-KB level and caspase-3 expression were studied immunohisto-
pathologically to evaluate lipid peroxidation, liver damage, and hepatocyte apoptosis.
The study investigators were blinded to group assignments.
The sham and 0] groups were compared to evaluate the effects of jaundice. Compari-
son of the 0] and 0] + LPS groups was made to evaluate the effects of sepsis in 0]. The
0] and 0] + sulfasalazine groups were compared to evaluate the potential therapeutic
effect of sulfasalazine in 0]. Comparison of the 0] + sulfasalazine + LPS and 0] + LPS +
sulfasalazine groups with the 0] + LPS group was made to evaluate the effects of
sulfasalazine in 0] + LPS. The 0] + sulfasalazine + LPS and 0] + LPS + sulfasalazine
groups were designed to evaluate the protective (before establishment of sepsis) or thera-
peutic (after establishment of sepsis) effect of sulfasalazine in 0] + LPS, respectively. The
0] + sulfasalazine + LPS and 0] + LPS + sulfasalazine groups were compared to deter-
mine when sulfasalazine was more effective, before or after establishment of sepsis.
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LIPID PEROXIDE ASSAYS
Liver Malondialdehyde Determination
The MDA levels, as an index of lipid peroxidation, were determined by thiobarbi-
turic acid (TBA) reaction according to Yagi.3l The principle of the method depends
on measurement of the pink color spectrophotometrically produced by interaction of
TBA with MDA elaborated as a result of lPS. The colored reaction was determined
at 553 nm using 1,1,3,3-tetraethoxypropane as the primary standard.3l The results
were expressed as nmol of MDA per gram of tissue.
Liver Myeloperoxidase Determination
The determination of tissue MPO activity, as an index of neutrophil infiltration,
depends on the fact that it reduces o-dianisidine. Reduced o-dianisidine was measured at
410 nm by spectrophotometry.32 The MPO activity was expressed as Dig of tissue.
HISTOLOGIC EVALUATION
Evaluation ofLiver Injury With Light Microscopy
The extracted liver tissues were fixed in 10% neutral formalin and subsequently
embedded in paraffin. Sections (5 j11ll) were deparaffinized in xylene and dehydrated
through graded concentrations of ethanol and stained with hematoxylin-eosin.
liver sections were graded with histopathology as described previously33: grade 0 =
no hepatocellular damage; grade 1 = minimal hepatocellular damage; grade 2 = minimal
centrolobular damage; grade 3 = severe centrolobular damage; grade 4 = centrolobular
and midzonal damage; grade 5 = severe centrolobular and midzonal damage; and
grade 6 = total hepatocellular destruction.
Immunohistochemical Staining Method for Nuclear Factor-KB
and Caspase-3 Expression
After blocking endogenous peroxidase activity with hydrogen peroxide, the
sections were heated in 0.01 moUl citrate buffer in a microwave cooker for 20 min-
utes. Sections were incubated using caspase-3 polyclonal antibody (dilution 11100,
RB-1197-BO labVision/Neomarkers, Fremont, California) and anti-NF-KB/p65
(Rel A) Ab-1 antibody (dilution 1I100RB-1638, labVision/Neomarkers) for 1 hour
at room temperature in a humidified chamber, and were then stained using the avidin-
biotin complex (ABC) immunoperoxidase technique with a commercially available
reagent (ABC kit, labVision). The sections were counterstained with Mayer's hema-
toxylin and mounted with mounting media (labVision).
Evaluation of Immunohistochemical Reactivity
Stained slides were categorized using a semiquantitative score according to the
staining intensity (SI) and the percentage of immunostained cells (SP) for each marker
(caspase-3 and NF-kB/p65) as described previously.34 SI was graded from 0 to 3 as
follows: grade 0 = no staining; grade 1 = weak staining; grade 2 = moderate staining;
and grade 3 = intense staining. SP was graded as follows: grade 0 = no staining; grade
1 = <25% staining of liver tissue; grade 2 = 25% to 50% staining of liver tissue;
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grade 3 = >50% to 75% staining ofliver tissue; and grade 4 = >75% staining of liver
tissue. Total staining score (TSS) was obtained as the sum of the SP and SI scores. TSS
was recorded using a scale of 0 to 7 (0 = no staining; 1-2 = mild staining; 3--4 =
moderate staining; 5-7 = highest staining).
STATISTICAL ANALYSIS
Biochemical values were described as mean (SEM). Statistical differences for liver
MDA and MPO activity values were evaluated using I-way ANOVA followed by the
Tukey post hoc test in SPSS version 11.5 (SPSS Inc., Chicago, Illinois). Histopatho-
logic examinations were presented as medians (interquartile range [IQR}). Compari-
sons of liver injury scores, staining scores for NF-KB, and caspase-3 expression were
analyzed using the Kruskal-Wallis test followed by the Dunn test (Statistica 6.1,
Statsoft Inc., Tulsa, Oklahoma). P < 0.05 was considered statistically significant. Box-plot
graphics were used to show the medians ofliver injury, NF-KB, and caspase-3 expres-
SlOn scores.
RESULTS
Forty-eight rats were evenly randomized to 6 groups of 8.
BIOCHEMICAL EXAMINATION
Liver Malondialdehyde
Mean (SEM) levels ofliver MDA were 34.26 (7.14) in the 0] group (n = 8),45.71
(6.45) in the 0] + LPS group (n = 8), 18.88 (0.83) in the 0] + sulfasalazine group (n =
8),26.34 (0.80) in the 0] + sulfasalazine + LPS group (n = 8),28.50 (1.13) in the
0] + LPS + sulfasalazine group (n = 8), and 12.42 (2.04) in the sham group (n =
8) (Figure 1).
Liver MDA increased significantly in the 0] group compared with the sham
group (P = 0.00l). Liver MDA was not significantly different between the 0] + LPS
and 0] groups. Liver MDA in the 0] + sulfasalazine group was significantly lower
than in the 0] group (P = 0.03). In the 0] + sulfasalazine + LPS and 0] + LPS +
sulfasalazine groups, liver MDA was significantly lower than in the 0] + LPS group
(P = 0.008 and P = 0.023, respectively). There was no statistically significant differ-
ence between the 0] + sulfasalazine + LPS and 0] + LPS + sulfasalazine groups.
Liver Myeloperoxidase
Mean (SEM) levels of liver MPO were 3.01 (0.07) in the 0] group, 4.64 (0.32) in
the 0] + LPS group, 0.94 (0.07) in the 0] + sulfasalazine group, 1.89 (0.10) in the
0] + sulfasalazine + LPS group, 2.23 (0.32) in the 0] + LPS + sulfasalazine group,
and 0.44 (0.04) in the sham group (Figure 2).
Liver MPO was increased significantly in the 0] group compared with the sham
group (P = 0.00l). Liver MPO in the 0] + LPS group was significantly higher than
that in the 0] group (P = 0.00l). Liver MPO was significantly lower in the 0] +
sulfasalazine group than in the 0] group (P = 0.001). In both the 0] + sulfasalazine +
LPS and 0] + LPS + sulfasalazine groups, liver MPO levels were significantly lower
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Figure 1. Mean (5EM) liver malondialdehyde (MDA) levels in male Wistar rats with ob-
structive jaundice (OJ) and lipopolysaccharide (LP5)-induced sepsis adminis-
tered sulfasalazine (5) before (OJ + 5 + LP5) and after (OJ + LP5 + 5) sepsis
(N = 48). *p = 0.001 versus the sham group; tp = 0.03 versus the OJ + 5 group;
'l'p = 0.008 versus the OJ + 5 + LP5 group; §p = 0.023 versus the OJ + LP5 +
5 group.
than that in the 0] + LPS group (both, P = 0.001). There was no statistically significant
difference between the 0] + sulfasalazine + LPS and 0] + LPS + sulfasalazine groups.
HISTOPATHOLOGIC EXAMINATION
Light Microscopic Evaluation ofLiver Injury
In the 0] + sulfasalazine group, minimal congestion in sinusoids was observed,
with degeneration in a few hepatocytes and spare centrolobular focal necrosis (grade 1).
In the 0] and 0] + LPS groups, severe centrolobular and midzonal necroses (grade 3)
were noted. Focal centrolobular necrosis (grade 2) was noted in the 0] + sulfasalazine +
LPS and 0] + LPS + sulfasalazine groups. Liver sections of the sham group showed
near-normal morphology (grade 0) (Figure 3).
Light Microscopic Evaluation of Immunohistochemical Staining ofNuclear
Factor-KB and Caspase-3 Expression in Liver Tissue
In the 0] and 0] + LPS groups, intense cytoplasmic staining (grade 3) was de-
tected in large areas with both NF-KB and caspase-3. Caspase-3 and NF-KB had
moderate cytoplasmic staining in perivenular hepatocytes (grade 2) in the 0] +
sulfasalazine, 0] + sulfasalazine + LPS, and 0] + LPS + sulfasalazine groups.
Both NF-KB and caspase-3 showed no cytoplasmic staining (grade 0) in hepatocytes
in the sham group (Figures 4 and 5).
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Figure 2. Mean (5EM) liver myeloperoxidase (MPO) levels in male Wistar rats with ob-
structive jaundice (OJ) and lipopolysaccharide (LP5)-induced sepsis adminis-
tered sulfasalazine (5) before (OJ + 5 + LP5) and after (OJ + LP5 + 5) sepsis
(N = 48). *p = 0.001 versus the sham group; tp = 0.001 versus the OJ + LP5
group; 'l'p = 0.001 versus the OJ + 5 group; §p = 0.001 versus the OJ + 5 + LP5
group; lip = 0.001 versus the OJ + LP5 + 5 group.
Statistical Evaluation ofLiver Injury Scores
Median (IQR) liver injury scores in the 0], 0] + LPS, 0] + sulfasalazine, 0] +
sulfasalazine + LPS, 0] + LPS + sulfasalazine, and sham groups were 3 (2-3),
3 (2-4), 1 (0-1),2 (1-3), 2 (2-2), and 0 (0-0), respectively (Figure 6).
Liver injury scores increased significantly in the 0] group compared with the sham
group (P = 0.002). There was no statistically significant between-group difference in the
0] and 0] + LPS groups. The mean liver injury score of the 0] + sulfasalazine group
was significantly lower than that of the 0] group (P = 0.033). There were no other
statistically significant between-group differences in regard to liver injury scores.
Statistical Evaluation ofNuclear Factor KB Expression
Median (IQR) NF-KB TSSs in the 0], 0] + LPS, 0] + sulfasalazine, 0] + sul-
fasalazine + LPS, 0] + LPS + sulfasalazine, and sham groups were 4 (3-5), 4 (3.5--4),
3 (2--4), 3 (3--4), 3 (2--4), and 1 (0-2), respectively (Figure 7).
NF-KB staining scores increased significantly in the 0] group compared with those
in the sham group (P = 0.003). There was no statistically significant difference between
staining scores in the 0] and 0] + LPS groups. There were no other statistically signifi-
cant between-group differences in regard to NF-KB staining scores.
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Figure 3. Representative light microscopic liver injury changes in the tissue of male
Wistar rats with obstructive jaundice (OJ) and lipopolysaccharide (LP5)-induced
sepsis administered sulfasalazine (5) before (OJ + 5 + LP5) and after (OJ + LP5 +
5) sepsis (magnification X100). (A) Normal liver parenchyma (grade 0) in the sham
group; (B) spare focal necrosis in the pericentral zone (grade 1) in the OJ + 5
group; focal centrolobular necrosis (grade 2) was noted in the (0) OJ + 5 + LP5
and (E) OJ + LP5 + 5 groups; large necrotic plaque extending from precentral
to periportal areas (grade 3) in the (C) OJ and (F) OJ + LP5 groups. Grade 0 = no
hepatocellular damage; grade 1 = minimal hepatocellular damage; grade 2 =
minimal centrolobular damage; grade 3 = severe centrolobular damage; grade
4 = centrolobular and midzonal damage; grade 5 = severe centrolobular and
midzonal damage; grade 6 = total hepatocellular destruction.33
Statistical Evaluation ofCaspase-3 Staining
Median (IQR) of caspase-3 TSSs in the 0],0] + iPS, 0] + sulfasalazine, 0] +
sulfasalazine + iPS, 0] + iPS + sulfasalazine, and sham groups were 4 (3-5),5 (4-5),
3 (2--4),4 (3-5), 4 (3-5), and 0 (0-2), respectively (Figure 8).
Caspase-3 expression scores increased significantly in the 0] group compared with
the sham group (P = 0.002). There were no other statistically significant between-
group differences observed in regard to caspase-3 expression scores.
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Figure 4. Representative nuclear factor 1d3 expression staining in the liver tissue of male
Wistar rats with obstructive jaundice (OJ) and lipopolysaccharide (LPS)-induced
sepsis administered sulfasalazine (S) before (OJ + S + LPS) and after (OJ + LPS +
S) sepsis (magnification X100). (A) No staining was detected (grade 0) in hepato-
cytes in the sham group; (B) moderate and focal cytoplasmic staining (grade 2) in
hepatocytes in the OJ + S, OJ + S + LPS, and OJ + LPS + S groups; and (C) intense
and diffuse cytoplasmic staining (grade 3) in hepatocytes in the OJ and OJ + LPS
groups. Staining intensity was graded from 0 to 3 as follows: grade 0 = no staining;
grade 1 = weak staining; grade 2 = moderate staining; grade 3 = intense
staining.
Figure 5. Representative caspase-3 expression staining in the liver tissue of male Wistar
rats with obstructive jaundice (OJ) and lipopolysaccharide (LPS)-induced sepsis
administered sulfasalazine (S) before (OJ + S + LPS) and after (OJ + LPS + S)
sepsis (magnification X100). (A) No staining was detected (grade 0) in hepato-
cytes in the sham group; (B) moderate and focal caspase-3 staining (grade 2)
in hepatocytes in the OJ + S, OJ + S + LPS, and OJ + LPS + S groups; and (C)
intense and diffuse caspase-3 staining (grade 3) in hepatocytes in the OJ and OJ +
LPS groups. Staining intensity was graded from 0 to 3 as follows: grade 0 = no
staining; grade 1 = weak staining; grade 2 = moderate staining; grade 3 = in-
tense staining.
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Figure 6. Box plot of median (interquartile range) liver injury scores in male Wistar rats
with obstructive jaundice (OJ) and lipopolysaccharide (LP5)-induced sepsis
administered sulfasalazine (5) before (OJ + 5 + LP5) and after (OJ + LP5 + 5)
sepsis (N = 48). *p = 0.002 versus the sham group; tp = 0.033 versus the OJ +
5 group.
DISCUSSION
The hepatic content of MPO reflects the nwnber of neutrophils in the liver. In the pres-
ent study, liver MPO, as an index of neutrophil infiltration, increased in association with
0], as mentioned in the literature. 35 The inflammatory process in both macrophages
and neutrophils has been found to be associated with activation of the transcription fac-
tor NF-KB.36 In unstimulated cells, NF-KB is bound to IKB-a, preventing its nuclear
localization. Upon activation, IKB-a is degraded and NF-KB translocates to the nucleus,
where it binds the promoter elements of genes for inflammatory cytokines and adhesion
proteins. 1s In the present study, there was overproduction ofNF-KB in the 0] group, as
mentioned in the literature. Activation of NF-KB leads to overproduction of cytokines
and other proinflammatory molecules such as iNOS and COX-2. These molecules and
cytokines lead to high lipid peroxidation and nitric oxide formation.
It has been suggested that oxidative stress associated with lipid peroxidation is
involved in the development of liver injury in 0]. Biliary obstruction is associated
with an intense state of oxidative stress. Extrahepatic BDL in rats has been found to
produce an important reduction of antioxidant defenses and exacerbation of lipid per-
oxidation in the livery-42 Nitric oxide reacts with free oxygen radicals, leading to the
formation of ONOO-, and this anion leads to lipid peroxidation, cellular damage, and
apoptosis. In our study, we observed that liver MDA, as an index of lipid peroxidation,
increased in the 0] group.
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Figure 7. Box plot of median (interquartile range) liver tissue nuclear factor lCB (NF-lCB) ex-
pression scores in male Wistar rats with obstructive jaundice (OJ) and lipopolysac-
charide (LP5)-induced sepsis administered sulfasalazine (5) before (OJ + 5 + LP5)
and after (OJ + LP5 + 5) sepsis (N = 48). *p = 0.003 versus the sham group.
Increased production of proinflammatory cytokines, lipid peroxidation, and endo-
toxins leads to liver damage and hepatocyte apoptosis; therefore, intrahepatic accumu-
lation of toxic bile acids also induces hepatocyte apoptosis. 37,43 The glycine conjugate
of chenodeoxycholate induces hepatocyte apoptosis in vitro, whereas the taurine con-
jugate does not. 39,44 Studies have reported that bile acids activate cytoplasmic protein
kinase cascades and function as ligands for the nuclear receptor farnesoid X re-
ceptor. 40 ,45 The nontoxic bile acid taurocholate has been found to activate phos-
phatidylinositol 3_kinase,1,14,41 a potent activator of survival signals.42 ,46 Bile salt
cytotoxicity both in vivo and in vitro is mediated by the death receptor Fas.3,47 Toxic
bile acids induce Fas oligomerization and activate caspases, most likely caspase-8,
resulting in apoptosis. 37 ,47 NF-KB may suppress bile acid-mediated Fas/caspase-8
activation by upregulating cIAP-l expression. This concept suggests that the net
effect of bile acids in mediating liver injury reflects a balance between pro- and anti-
apoptotic processes. For this reason, we observed a high rate of caspase-3 expression in
the 0] group in our study. As a result of these mechanisms and mediators responsible
for the pathogenesis of liver damage in 0], we observed a high rate of liver injury
scores in the 0] group in the present study.
In the 0] + iPS group, we observed significantly greater neutrophil accumulation,
supported by a high level ofliver MPO. This can be explained by the fact that in 0],
there is depression in the clearance of iPS and other endotoxins in the portal circula-
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Figure 8. Box plot of median (interquartile range) liver tissue caspase-3 expression
scores in male Wistar rats with obstructive jaundice (OJ) and lipopolysaccha-
ride (LP5)-induced sepsis administered sulfasalazine (5) before (OJ + 5 + LP5)
and after (OJ + LP5 + 5) sepsis (N = 48). *P = 0.002 versus the sham
group.
tion by Kuppfer cells in the liver. 4s Increased sensitivity to iPS endotoxin leads to
exaggerated lipid peroxidation and accumulation of neutrophils, which then lead to
organ dysfunction. 12,15,16 However, NF-KB expression in the 0] + iPS group was as
high as NF-KB expression in the 0] group. Although NF-KB expression was high, it
did not increase as high as expected. This might be explained by the fact that NF-KB
activated by iPS induces IKB and contributes to the downregulation of this intracel-
lular signaling cascade. 1s In our study, we observed that caspase-3 expression in the
0] + iPS group was as high as that in the 0] group. This suggests that NF-KB is also
a potent antiapoptotic agent and that massive apoptosis does not occur as one might
expect. 49 However, exaggerated lipid peroxidation and accumulation of toxic hydro-
phobic bile salts within hepatocytes cause hepatocyte toxicity that leads to liver dam-
age. For this reason, there were increased liver injury scores in the 0] + iPS group.
Previous studies have found that sulfasalazine is a potent NF-KB inhibitor. 26- 2s
Because NF-KB plays a role in lipid peroxidation, neutrophil accumulation, and he-
patocyte apoptosis, we administered sulfasalazine to jaundiced rats to see whether it
exerted any beneficial effect on these events. In the 0] + sulfasalazine group, we ob-
served that there was a reduction, though not statistically significant, in NF-KB and
caspase-3 expression. Blocking a single mediator, especially after the initial attack to
the host, might be insufficient to inhibit NF-KB significantly because of the redun-
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dancy of proximal mediators with the potential to activate NF_KB.50,51 However, liver
MDA and MPO levels were significantly lower compared with the 0] group. Treat-
ment with sulfasalazine might alleviate liver oxidative damage, proinflammatory cyto-
kine production, ductular proliferation, and neutrophil infiltration. 28 In addition, sul-
fasalazine has antioxidative properties; it is a strong scavenger of free radicals. 27 Lipid
peroxidation was attenuated with the inhibitory effect of sulfasalazine on neutrophil
infiltration rather than its inhibitory effect on NF-KB production and caspase-3 expres-
sion. Because one of the potential sources of liver injury in 0] is lipid peroxidation,
sulfasalazine likely decreases liver injury scores via attenuating lipid peroxidation.
There are several factors reported in the literature that are thought to affect hepatocyte
apoptosis besides lipid peroxidation. High NF-KB production suppresses hepatocyte apop-
tosis.49 Reduction, though not statistically significant, in NF-KB production with sul-
fasalazine, as reported in the present study, and retention and accumulation of toxic hydro-
phobic bile salts within hepatocytes may aggravate hepatocyte apoptosis. Retention
and accumulation of nontoxic bile acid taurocholate within hepatocytes may activate
phosphatidylinositol3-kinase, a potent activator of survival signals, and may reduce hepa-
tocyte apoptosis.42 ,46 Apoptotic and antiapoptotic processes balance the rate of hepatocyte
apoptosis. In the present study, we observed a numerical, though not statistically signifi-
cant, reduction in caspase-3 expression in the 0] + sulfasalazine group. Therefore,
sulfasalazine might attenuate histologic liver damage via attenuating lipid peroxidation
rather than inhibiting NF-KB production and caspase-3 expression.
Administration of sulfasalazine in jaundiced rats before or after LPS-induced sepsis
(0] + sulfasalazine + LPS and 0] + LPS + sulfasalazine groups) led to a reduction,
though not statistically significant, in NF-KB production, caspase-3 expression, and
liver injury scores. Since cholestasis is the initial attack to the host, sepsis established
after cholestasis is the second attack. For this reason, sepsis in 0] creates a chaotic
and uncontrollable condition in which there is a pool of proinflammatory cytokines,
molecules, mediators, and inflammatory cells. Therefore, blocking a single mediator
in this chaotic condition might inhibit NF-KB expression insignificantly. Sulfasalazine
induces apoptosis in T-lymphocytes and neutrophils. 52 This leads to attenuation in
lipid peroxidation and neutrophil accumulation in 0] with sepsis. However, blocking
only 1 of the potential sources of liver injury in 0] with sepsis might attenuate liver
injury scores and caspase-3 expression insignificantly. For this reason, we observed no
statistically significant changes in caspase-3 expression and liver injury scores in these
groups. As a result of these findings, we can conclude that sulfasalazine failed to attenu-
ate histologic liver damage in 0] with sepsis. When the 0] + sulfasalazine + LPS and
0] + LPS + sulfasalazine groups were compared, there were no significant differences
observed in any of the study end points. Therefore, administration of sulfasalazine in
jaundiced rats before or after the induction of sepsis was equivalent, and it failed to
attenuate histologic liver damage when there was sepsis.
STUDY LIMITATIONS
The small number of rats in each arm of the study made the interpretation of histo-
pathologic results difficult. Also, the dose of sulfasalazine used in the treatment or
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pretreatment of sepsis in 0] might have been too low to inhibit NF-KB, caspase-3
expression, and histologic liver damage. Further investigations with larger num-
bers of subjects and higher doses of sulfasalazine are needed to clarify the findings
of this study.
CONCLUSIONS
Because sulfasalazine did not decrease NF-KB production and caspase-3 expression in
these male Wistar rats, histologic liver damage in the 0] + sulfasalazine group was
thought to be attenuated via decreased neutrophil accumulation and lipid peroxida-
tion. Administration of sulfasalazine to jaundiced rats prior to or after iPS-induced
sepsis was associated with a reduction in lipid peroxidation and neutrophil accumu-
lation, but not in NF-KB production or caspase-3 expression. Sulfasalazine failed to
attenuate histologic liver damage in 0] aggravated with sepsis (iPS). There was no
difference between the findings when sulfasalazine was administered before (0] +
sulfasalazine + iPS) or after sepsis (0] + iPS + sulfasalazine).
ACKNOWLEDGMENT
The authors have indicated that they have no conflicts of interest regarding the con-
tent of this article.
REFERENCES
1. Greig JD, Krukowski ZH, Matheson NA. Surgical morbidity and mortality in one hundred
and twenty-nine patients with obstructive jaundice. Br] Surg 1988;75:216-219.
2. Tracy TF Jr, Fox ES. Molecular and cellular control points in pediatric liver injury and repair.
Semin Pediatr Surg. 1996;5:175-181.
3. Miyoshi H, Rust C, Roberts PJ, et al. Hepatocyte apoptosis after bile duct ligation in the
mouse involves Fas. Gastroenterology. 1999;117:669-677.
4. Miyoshi H, Rust C, Guicciardi ME, Gores GJ. NF-KB is activated in cholestasis and functions
to reduce liver injury. Am] Pathol. 2001;158:967-975.
5. Lechner AJ, Velasquez A, Knudsen KR, et al. Cholestatic liver injury increases circulating
TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia. Am] Respir Crit Care Med.
1998;157: 1550-1558.
6. Liu TZ, Lee KT, Chern CL, et al. Free radical-triggered hepatic injury of experimental obstruc-
tive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced acti-
vation of nuclear factor kappa B. Ann Clin Lab Sci. 2001;31:383-390.
7. Jolobe OM. Role of endotoxin and nitric oxide in the pathogenesis of renal failure in obstruc-
tive jaundice. Br] Surg. 1997;84:1747.
8. Arriero MM, Lopez-Farre A, Fryeiro 0, et al. Expression of inducible nitric oxide synthase in
the liver of bile duct-ligated Wistar rats with modulation by lymphomononuclear cells. Sur-
gery.2001;129:255-266.
9. Moazzam FN, Brems JJ, Yong SL, et al. Endotoxin potentiates hepatocyte apoptosis in
cholestasis.] Am Colt Surg. 2002;194:731-739.
10. Ito Y, Machen NW, Urbaschek R, McCuskey RS. Biliary obstruction exacerbates the hepatic
microvascular inflammatory response to endotoxin. Shock. 2000;14:599-604.
11. Houdijk AP, van Lambalgen AA, Thijs LG, van Leeuwen PA. Gut endotoxin restriction im-
proves postoperative hemodynamics in the bile duct-ligated rat. Shock. 1998;9:282-288.
313
CURRENT THERAPEUTIC RESEARCH
12. Regan MC, Keane RM, Little D, Bouchier-Hayes D. Postoperative immunological function
and jaundice. Br] Surg. 1994;81:271-273.
13. Scott-Conner CE, Grogan JB. The pathophysiology of biliary obstruction and its effect on
phagocytic and immune function.] Surg Res. 1994;57:316-336.
14. Saito JM, Maher J], Bile duct ligation in rats induces biliary expression of cytokine-induced
neutrophil chemoattractant. Gastroenterology. 2000;118: 1157-1168.
15. Plusa S, Webster N, Primrose], Obstructive jaundice causes reduced expression of polymor-
phonuclear leucocyte adhesion molecules and a depressed response to bacterial wall products in
vitro. Gut. 1996;38:784-787.
16. Sheen-Chen SM, Chau P, Harris HW Obstructive jaundice alters Kupffer cell function inde-
pendent of bacterial translocation.] Surg Res. 1998;80:205-209.
17. Shimizu Y, Miyazaki M, Ito H, et al. Enhanced endothelial cell injury by activated neutrophils
in patients with obstructive jaundice.] Hepatol. 1997;27:803-809.
18. Christman JW, Lancaster LH, Blackwell TS. Nuclear factor kappa B: A pivotal role in the
systemic inflammatory response syndrome and new target for therapy. Intensive Care Med.
1998;24:1131-1138.
19. Casini A, Ceni E, Salzano R, et al. Neutrophil-derived superoxide anion induces lipid peroxida-
tion and stimulates collagen synthases in human hepatic stellate cells: Role of nitric oxide.
Hepatology. 1997;25: 361-367.
20. Szabo C, Cuzzocrea S, Zingarelli B, et al. Endothelial dysfunction in a rat model of endotoxic
shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite.] Clin
Invest. 1997;100:723-735.
21. Szabo C, Dawson Vi. Role of poly(ADP-ribose) synthetase in inflammation and ischemia-
reperfusion. Trends Pharmacol Sci. 1998;19:287-298.
22. Krahenbuhl S, Talos C, Lauterburg BH, Reichen], Reduced antioxidative capacity in liver
mitochondria from bile duct ligated rats. Hepatology. 1995;22:607-612.
23. Parola M, Leonarduzzi G, Robino G, et al. On the role oflipid peroxidation in the pathogenesis
of liver damage induced by long-standing cholestasis. Free Radic BioI Med. 1996;20:351-359.
24. Alptekin N, Mehmet<;ik G, Uysal M, Ayka<;-toker G. Evidence for oxidative stress in the he-
patic mitochondria of bile duct ligated rats. Pharmacol Res. 1997;36:243-247.
25. Tsai LY, Lee KT, Liu TZ. Evidence for accelerated generation of hydroxyl radicals in experimental
obstructive jaundice of rats. Free Radic BioI Med. 1998;24:732-737.
26. Wahl C, Liptay S, Adler G, Schmid RM. Sulfasalazine: A potent and specific inhibitor of nuclear
factor kappa B.] Clin Invest. 1998;101:1163-1174.
27. Aruoma 01, Wasil M, Halliwell B, et al. The scavenging of oxidants by sulphasalazine and its
metabolites. A possible contribution to their anti-inflammatory effect? Biochem Pharmacol.
1987;36:3739-3742.
28. Demirbilek S, Akin M, Gurunluoglu K, et al. The NF-kappaB inhibitors attenuate hepatic
injury in bile duct ligated rats. Pediatr Surg Int. 2006;22:655-663.
29. Turkish Republic Organic Law. Code number 5199: Animal experiments; Rule 9 [in Turkish}.
http://www.cevreorman.gov.tr/yasa/k/25509.doc. Accessed August 1, 2009.
30. Lee E. The effect of obstructive jaundice on the migration of reticulo-endothelial cells and fi-
broblasts into early experimental granulomata. Br] Surg. 1972;59:875-877.
31. Yagi K. Lipid peroxides and related radicals in clinical medicine. In: Armstrong D, ed. Free
Radicals in Diagnostic Medicine. New York, NY: Plenum Press; 1994:1-15.
32. Golowich SP, Kaplan SD, eds. Methods in Enzymology. Vol II. New York, NY: Academic Press;
1955:769.
314
M. DIRLIK ET AL.
33. Tsimoyiannis EC, Moutesidou KJ, Moschos CM, et al. Trimetazidine for prevention of hepatic
injury induced by ischaemia and reperfusion in rats. Eur] Surg. 1993;159:89-93.
34. Lesnikova I, Lidang M, Hamilton-Dutoit S, Koch J. p16 as a diagnostic marker of cervical
neoplasia: A tissue microarray study of 796 archival specimens. Diagn Pathol. 2009;4:22.
35. Naito Y, Takagi T, Uchiyama K, Handa 0, et al. Suppression of intestinal ischemia-reperfusion
injury by a specific peroxisome proliferator-activated receptor-gamma ligand, pioglitazone, in
rats. Redox Rep. 2002;7:294-299.
36. Barnes PJ. Nuclear factor-kappa B. Int] Biochem Cell BioI. 1997;29:867-870.
37. Faubion WA, Guicciardi ME, Miyoshi H, et al. Toxic bile salts induce rodent hepatocyte apop-
tosis via direct activation ofFas.] Clin Invest. 1999;103:137-145.
38. Patel T, Roberts LR, Jones BA, Gores GJ. Dysregulation of apoptosis as a mechanism of liver
disease: An overview. Semin Liver Dis. 1998;18:105-114.
39. Patel T, Bronk SF, Gores GJ. Increases of intracellular magnesium promote glycodeoxycholate-
induced apoptosis in rat hepatocytes.] Clin Invest. 1994;94:2183-2192.
40. Parks DJ, Blanchard SG, Bledsoe RK, et al. Bile acids: Natural ligands for an orphan nuclear
receptor. Science. 1999;284: 1365-1368.
41. Misra S, Ujhazy P, Gatmaitan Z, et al. The role of phosphoinositide 3-kinase in taurocholate-
induced trafficking of ATP-dependent canalicular transporters in rat liver. ] BioI Chem.
1998;273:26638-26644.
42. Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apop-
tosis by nerve growth factor. Science. 1995;267:2003-2006.
43. Aldana PR, Goerke ME, Carr SC, Tracy TF Jr. The expression of regenerative growth factors in
chronic liver injury and repair.] Surg Res. 1994;57:711-717.
44. Fox ES, Kim JC, Tracy TF. NF-kappaB activation and modulation in hepatic macrophages
during cholestatic injury.] Surg Res. 1997;72:129-134.
45. Koeppel TA, Trauner M, Baas JC, et al. Extrahepatic biliary obstruction impairs microvascular
perfusion and increases leukocyte adhesion in rat liver. Hepatology. 1997;26:1085-1091.
46. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu
Rev Immunol. 1994;12:141-179.
47. Singh S, Shackleton G, Ah-Sing E, et al. Antioxidant defenses in the bile duct-ligated rat.
Gastroenterology. 1992;103: 1625-1629.
48. Reynolds JV, Murchan P, Redmond HP, et al. Failure ofmacrophage activation in experimental
obstructive jaundice: Association with bacterial translocation. Br] Surg. 1995;82:534-538.
49. Lin A, Karin M. NF-kappaB in cancer: A marked target. Semin Cancer BioI. 2003;13:107-114.
50. Weikert LF, Bernard GR. Pharmacotherapy of sepsis. Clin Chest Med. 1996;17:289-305.
51. Christman JW, Holden EP, Blackwell TS. Strategies for blocking the systemic effects of
cytokines in the sepsis syndrome. Crit Care Med. 1995;23:95 5-963.
52. Liptay S, Fulda S, Schanbacher M, et al. Molecular mechanisms of sulfasalazine-induced T-cell
apoptosis. Br] Pharmacol. 2002;137:608-620.
ADDRESS CORRESPONDENCE TO: Musa Dirlik, MD, General Surgery
Department, Faculty of Medicine, Mersin University Medical School, Zeytinlibah<;e
Caddesi, Eski Otogar Yam, 33079, Mersin, Turkey. E-mail: musa.dirlik@yahoo.com
315
